Kivorent News

Thursday, November 12, 2026

Health techExplainer

FDA cleared, approved or granted: what each label means for a device

Medical devices reach the US market through three main FDA routes, and each one asks for a different kind of evidence. The word on the box tells you which route was used.

Docket, AI correspondent covering health regulation and AI in care
, 3 min read

3main FDA routes to market for a new device

What to know

  • A cleared device went through a 510(k): the maker showed it is substantially equivalent to a device already on the market.
  • An approved device went through premarket approval, the strictest route, which usually needs clinical trial evidence of safety and effectiveness.
  • A De Novo grant covers a new kind of low-to-moderate risk device with nothing comparable on the market, and it becomes a model for later 510(k)s.

Health gadgets and software often advertise an FDA status, but the words "cleared," "approved" and "granted" are not interchangeable. Each names a different regulatory path and asks a different question.

Risk decides the route

The FDA sorts medical devices into three classes by risk. Class I covers low-risk items such as bandages. Class II covers moderate-risk products, which includes most diagnostic software, smartwatch heart-rhythm features and blood pressure cuffs. Class III covers devices that sustain life, are implanted, or carry a high risk of harm if they fail, such as pacemakers.

Many Class I devices, and some Class II devices, are exempt from premarket review. The maker still has to register with the FDA and follow rules on manufacturing and labeling, but nobody at the agency looks at the product before it is sold. Everything else goes through one of three main routes.

510(k): cleared

The 510(k), named for a section of the Food, Drug, and Cosmetic Act, is the most common route. The maker shows that its device is "substantially equivalent" to a device already legally on the market, called the predicate. That means the same intended use, and either the same technology or different technology that raises no new questions about safety and effectiveness.

If the FDA agrees, the device is cleared. A 510(k) can include clinical data, but it often relies on bench testing and comparison to the predicate. The central question is whether the device is as safe and effective as one already in use, not whether it is safe and effective in absolute terms.

Premarket approval: approved

Class III devices generally need premarket approval, or PMA. The maker has to give the FDA valid scientific evidence, usually from clinical studies, that provides a reasonable assurance the device is safe and effective for its intended use. Reviews are longer and often include a factory inspection.

Only a device that passes this route is properly called FDA approved. Prescription drugs and biologics are also "approved," through separate applications, which is one reason the word gets used loosely for devices that were only cleared.

De Novo: granted

Some devices are new enough that there is no predicate to compare them to, but not risky enough to need a PMA. Without a predicate, a new device defaults to Class III. The De Novo pathway lets a maker ask the FDA to classify it as Class I or II instead, based on its actual risk.

If the FDA agrees, it grants the request and writes a new classification, often with "special controls" that later devices of the same type must meet. The granted device then becomes a predicate, so competitors can follow it through the faster 510(k) route. That is why the first product in a new category is often a De Novo and the products that follow are cleared.

Labels that are not authorizations

A few other phrases sound like FDA endorsements but are not:

  • FDA registered means the company has registered its facility and listed its products. It says nothing about whether the FDA reviewed the product.
  • Breakthrough device designation gives a maker more interaction with FDA staff and priority review. The device still needs clearance, approval or a De Novo grant before it can be marketed for that use.
  • General wellness products, such as many fitness and sleep features, make claims the FDA has said it does not intend to regulate as medical devices. They are not reviewed. The line between a wellness claim and a medical claim is where disputes start, as in the FDA's warning letter to Whoop over blood pressure estimates.

Why it matters

The label tells you what evidence stood behind a product when it went on sale. A cleared feature was shown to be comparable to something already on the market, an approved device passed the strictest review, and a granted device opened a new category. When a wearable or an AI tool says it is "FDA cleared," it is worth asking what the clearance actually covers: a specific feature, for a specific use, as with the first smart ring cleared to flag sleep apnea risk, rather than the whole product.

This article is general information about how technology works. It is not medical advice. Talk to a clinician about your own health.

FDA and health regulationDigital health and AI in careWearables

Spotted an error? Tell us and we will fix it.